hexamethonium has been researched along with Anxiety in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"In the present study, the effect of alpha-adrenoceptor agents on response to nicotine in an anxiety model (elevated plus-maze) in mice was investigated." | 3.70 | Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. ( Babaie, A; Etminani, A; Gharib, B; Homayoun, H; Zarrindast, MR, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Roni, MA | 1 |
Rahman, S | 1 |
Zarrindast, MR | 1 |
Homayoun, H | 1 |
Babaie, A | 1 |
Etminani, A | 1 |
Gharib, B | 1 |
2 other studies available for hexamethonium and Anxiety
Article | Year |
---|---|
Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Blood-Brain Barrier; Brain; Exploratory Behavior; Hexamethoni | 2011 |
Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anxiety; Atropine; Clonidine; Hexa | 2000 |